Previous studies have underscored the clinical relevance of Gal-3 in patients with heart failure; in heart failure accompanied by acute or chronic kidney disease; in heart failure with diabetes; and in kidney disease coexisting with diabetes. Here, LGALS3 is linked to kidney disorder.